Marco Triggiani

845 total citations
19 papers, 456 citations indexed

About

Marco Triggiani is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Marco Triggiani has authored 19 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Marco Triggiani's work include Heart Failure Treatment and Management (7 papers), Cardiovascular Function and Risk Factors (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Marco Triggiani is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Cardiovascular Function and Risk Factors (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Marco Triggiani collaborates with scholars based in Italy, United States and Germany. Marco Triggiani's co-authors include Savina Nodari, Mihai Gheorghiade, Livio Dei, Alessandra Manerba, Giuseppe Milesi, Umberto Campia, Bruno Mario Cesana, Muthiah Vaduganathan, Michele Senni and Javed Butler and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Marco Triggiani

18 papers receiving 444 citations

Peers

Marco Triggiani
Marco Triggiani
Citations per year, relative to Marco Triggiani Marco Triggiani (= 1×) peers Alessandra Manerba

Countries citing papers authored by Marco Triggiani

Since Specialization
Citations

This map shows the geographic impact of Marco Triggiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Triggiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Triggiani more than expected).

Fields of papers citing papers by Marco Triggiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Triggiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Triggiani. The network helps show where Marco Triggiani may publish in the future.

Co-authorship network of co-authors of Marco Triggiani

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Triggiani. A scholar is included among the top collaborators of Marco Triggiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Triggiani. Marco Triggiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Becattini, Cecilia, Ludovica Anna Cimini, Giorgio Bassanelli, et al.. (2023). Acute pulmonary embolism and cancer: findings from the COPE study. Clinical Research in Cardiology. 113(2). 288–300. 4 indexed citations
2.
Antohi, Elena‐Laura, Riccardo M. Inciardi, Pietro Mazzeo, et al.. (2023). Rationale and Design of the Biventricular Evaluation of Gliflozins Effects In chroNic Heart Failure: BEGIN-HF Study. ESC Heart Failure. 10(3). 2066–2073. 3 indexed citations
3.
Correale, Michele, Stefano Coiro, Elena‐Laura Antohi, et al.. (2021). Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?. Heart Failure Reviews. 27(4). 1147–1163. 8 indexed citations
4.
Pernigo, Matteo, et al.. (2021). Acute heart failure due to COVID-19 related myocardial injury and de novo hypertensive cardiomyopathy: a challenging diagnosis. Monaldi Archives for Chest Disease. 92(1). 1 indexed citations
5.
Pernigo, Matteo, et al.. (2019). Giant right coronary artery aneurysm detected by transthoracic echocardiography. Journal of Cardiovascular Echography. 29(1). 29–29. 1 indexed citations
6.
Düngen, Hans‐Dirk, Michele Correale, Stefano Coiro, et al.. (2018). A new educational program in heart failure drug development: the Brescia international master program. Journal of Cardiovascular Medicine. 19(8). 411–421. 7 indexed citations
7.
Mercurio, Valentina, Alberto Palazzuoli, Michele Correale, et al.. (2018). Right heart dysfunction: from pathophysiologic insights to therapeutic options: a translational overview. Journal of Cardiovascular Medicine. 19(11). 613–623. 7 indexed citations
8.
Greene, Stephen J., Javed Butler, Gregg C. Fonarow, et al.. (2017). Pre-Discharge and Early Post-Discharge Troponin Elevation Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction: Findings from the ASTRONAUT Trial. European Journal of Heart Failure. 20(2). 281–291. 24 indexed citations
9.
Greene, Stephen J., Faı̈ez Zannad, Gregg C. Fonarow, et al.. (2016). Abstract 12886: In-hospital and Early Post-discharge Troponin Elevations Among Patients Hospitalized for Heart Failure: Insights From the ASTRONAUT Trial. Circulation. 134(suppl_1). 1 indexed citations
10.
Dessalvi, Christian Cadeddu, Valentina Mercurio, Paolo Spallarossa, et al.. (2016). Preventing antiblastic drug-related cardiomyopathy. Journal of Cardiovascular Medicine. 17. e64–e75. 23 indexed citations
11.
Vaduganathan, Muthiah, Giuseppe De Palma, Alessandra Manerba, et al.. (2016). Risk of Cardiovascular Hospitalizations from Exposure to Coarse Particulate Matter (PM10) Below the European Union Safety Threshold. The American Journal of Cardiology. 117(8). 1231–1235. 38 indexed citations
12.
Vaduganathan, Muthiah, Alexander Michel, Kathryn T. Hall, et al.. (2015). Spectrum of Epidemiological and Clinical Findings in Patients with Heart Failure with Preserved Ejection Fraction Stratified by Study Design: A Systematic Review. European Journal of Heart Failure. 18(1). 54–65. 71 indexed citations
13.
Triggiani, Marco, Alessandra Manerba, Laura Lupi, et al.. (2014). Impact of Multidisciplinary Personalized Disease Management Program on Readmission Rate after Discharge in Heart Failure Patients. Journal of Cardiac Failure. 20(8). S112–S112. 1 indexed citations
14.
Nodari, Savina, Marco Triggiani, Umberto Campia, & Livio Dei. (2012). Omega-3 Polyunsaturated Fatty Acid Supplementation: Mechanism and Current Evidence in Atrial Fibrillation.. PubMed. 5(4). 718–718. 6 indexed citations
15.
Nodari, Savina, Marco Triggiani, Umberto Campia, et al.. (2011). Effects of n-3 Polyunsaturated Fatty Acids on Left Ventricular Function and Functional Capacity in Patients With Dilated Cardiomyopathy. Journal of the American College of Cardiology. 57(7). 870–879. 165 indexed citations
16.
Nodari, Savina, Marco Triggiani, Alessandra Manerba, Giuseppe Milesi, & Livio Dei. (2011). Effects of supplementation with polyunsaturated fatty acids in patients with heart failure. Internal and Emergency Medicine. 6(S1). 37–44. 9 indexed citations
17.
Nodari, Savina, Marco Triggiani, Umberto Campia, et al.. (2011). n-3 Polyunsaturated Fatty Acids in the Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion. Circulation. 124(10). 1100–1106. 83 indexed citations
18.
Nodari, Savina, et al.. (2010). USE OF N-3 POLYUNSATURATED FATTY ACIDS TO MAINTAIN SINUS RHYTHM AFTER CONVERSION FROM PERSISTENT ATRIAL FIBRILLATION. A PROSPECTIVE RANDOMIZED STUDY. Journal of the American College of Cardiology. 55(10). A2.E14–A2.E14. 4 indexed citations
19.
Donatelli, Francesco, Marco Pocar, Marco Triggiani, et al.. (1998). Surgery of Cavo-Atrial Renal Carcinoma Employing Circulatory Arrest: Immediate and Mid-Term Results. Cardiovascular Surgery. 6(2). 166–170.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026